Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 81 for “"Pyrazinamide"”.

  1. Chitosan beads as a delivery vehicle for the antituberculosis drug pyrazinamide

    … as possible controlled release formulations. Pyrazinamide was chosen as the model drug. Chitosan beads and excipient containing chitosan beads were prepared by ionotropic gelation in tripolyphosphate. In this study chitosan/pyrazinamide beads containing pharmaceutical excipients (Ascorbic …

    nwu-za Repository record for Chitosan beads as a delivery vehicle for the antituberculosis drug pyrazinamide (opens in a new tab)

  2. Identification and characterization of mutations that confer resistance to ethambutol and pyrazinamide in Mycobacterium tuberculosis

    … anti-tuberculosis drugs ethambutol and pyrazinamide detects mutations in embB and pncA, respectively. However, discordance between phenotypic and molecular methods is described for both drugs. Aims: This study sought to (1) evaluate and compare ethambutol resistance using phenotypic and …

    manitoba Repository record for Identification and characterization of mutations that confer resistance to ethambutol and pyrazinamide in Mycobacterium tuberculosis (opens in a new tab)

  3. Investigation of surface interactions of pyrazinamide and pyrazinoic acid with synthetic and natural lipid membrane model systems

    Pyrazinamide (PZA) is a pro-drug used in the treatment of tuberculosis. Upon administration of the drug, it is converted to its active form of pyrazinoic acid (POA) by the tuberculosis bacterium; this is believed to be the biologically active form of the drug which exerts anti-tubercular activity. …

    colostate Repository record for Investigation of surface interactions of pyrazinamide and pyrazinoic acid with synthetic and natural lipid membrane model systems (opens in a new tab)

  4. D-optimal design of a pediatric pharmacokinetic study of a fixed dose combination product of rifampicin-pyrazinamide-isoniazid for the treatment of tuberculosis

    Ο σκοπός αυτής της εργασίας είναι να σχεδιαστεί μια παιδιατρική φαρμακοκινητική μελέτη αραιής δειγματοληψίας ενός φαρμακευτικού σκευάσματος σταθερού συνδυασμού δόσης, ισονιαζίδης, ριφαμπικίνης και πυραζιναμίδης για την θεραπεία της φυματίωσης. Θεωρείται ότι θα δοθεί μια μοναδική χορήγηση του …

    athens Repository record for D-optimal design of a pediatric pharmacokinetic study of a fixed dose combination product of rifampicin-pyrazinamide-isoniazid for the treatment of tuberculosis (opens in a new tab)

  5. Synthesis and structure determination of new pharmaceutical cocrystals

    … (API) without changing its chemical properties. Pyrazinamide is anti-bacterial drug which is used to treat tuberculosis that infects the lung tissues. In this thesis, the ability of pyrazinamide to form co-crystals with different di-carboxylic acids through the formation of strong hydrogen bonds …

    birmingham Download PDF for Synthesis and structure determination of new pharmaceutical cocrystals (opens in a new tab)

  6. The PH-dependent activity and the protonophoric mechanism of pyrazinoic acid and its structural analogues

    Pyrazinamide is an anti tubercle drug used in the standard treatment regimen against Mycobacterium tuberculosis, the cause of tuberculosis infections. The mechanism of action of pyrazinamide requires its enzymatic conversion to pyrazinoate, but the final molecular target of pyrazinoate is …

    colostate Repository record for The PH-dependent activity and the protonophoric mechanism of pyrazinoic acid and its structural analogues (opens in a new tab)

  7. Targeting Mycobacterium tuberculosis intrinsic resistance mechanisms to potentiate antitubercular drug action

    … antitubercular drugs p-aminosalicylic acid and pyrazinamide. The interrogation of these responses has led to improved understanding of the underlying mechanisms conferring intrinsic resistance to each drug. Leveraging our observations, we were able to improve the antitubercular action of …

    umn Repository record for Targeting Mycobacterium tuberculosis intrinsic resistance mechanisms to potentiate antitubercular drug action (opens in a new tab)

  8. An investigation into the molecular genetics of cell wall biosynthesis in Mycobacterium leprae

    … strains more sensitive to penicillin G(5) and pyrazinamide (1). The pyrazinamide sensitive mutant, Pyramidll was further characterised and found to be 20% more sensitive to pyrazinamide than the M. smegmatis mc2155 wild type strain. Pyramidll was found to be less hydrophobic than the wild type …

    lshtm Repository record for An investigation into the molecular genetics of cell wall biosynthesis in Mycobacterium leprae (opens in a new tab) Download PDF for An investigation into the molecular genetics of cell wall biosynthesis in Mycobacterium leprae (opens in a new tab)

  9. Estudo de pré-formulação para dose fixa combinada dos tuberculostáticos rifampicina, isoniazida, pirazinamida e etambutol (4 em 1)

    … treatment drugs: rifampicin, isoniazid, pyrazinamide and ethambutol and pharmaceutical excipients (lactose, cellulose, magnesium stearate and talc), in order to develop an FDC product (150 mg of rifampicin + 75 mg of isoniazid + 400 mg of pyrazinamide + 250 mg of ethambutol). The studies …

    brazil-ufrn Repository record for Estudo de pré-formulação para dose fixa combinada dos tuberculostáticos rifampicina, isoniazida, pirazinamida e etambutol (4 em 1) (opens in a new tab)

  10. Síntese e caracterização de complexos de ferro do tipo trans - Na2(Fe(CN)4(L)2) em que L são os ligantes amino, pirazinamida e Isoniazida

    … type in which L are the ligands, amino, pyrazinamide and isoniazid. The tetracyanos were obtained from the precursor compound NAT211 - Na2[Fe(CN)4(NH3)2] – dissolved in water followed by addition of the ligands, under stirring. With the vibrational spectra in the infrared region it was …

    brazil-ufrn Repository record for Síntese e caracterização de complexos de ferro do tipo trans - Na2(Fe(CN)4(L)2) em que L são os ligantes amino, pirazinamida e Isoniazida (opens in a new tab)

  11. A MULTIDISCIPLINARY INVESTIGATION OF TUBERCULOSIS: MATHEMATICAL AND EXPERIMENTAL STUDIES OF NATURAL HISTORY, DRUG RESISTANCE BIOLOGY, AND MDR-TB TRANSMISSION

    … we investigated the molecular mechanisms of pyrazinamide action on TB inhibition; and we modeled the influence of multidrug resistant TB (MDR-TB) transmission efficiency on long-term projections of the TB epidemic. Results: Our mathematical framework effectively links individual disease …

    jhu Repository record for A MULTIDISCIPLINARY INVESTIGATION OF TUBERCULOSIS: MATHEMATICAL AND EXPERIMENTAL STUDIES OF NATURAL HISTORY, DRUG RESISTANCE BIOLOGY, AND MDR-TB TRANSMISSION (opens in a new tab)

  12. Quality specifications for antituberculosis fixed dose combination products

    … and isoniazid tablets; rifampicin, isoniazid and pyrazinamide tablets; and rifampicin, isoniazid, pyrazinamide and ethambutol hydrochloride tablets. Background: Tuberculosis (TB), caused by Mycobacterium tuberculosis, is an airborne disease that mainly affects the lungs. TB is currently causing a …

    nwu-za Repository record for Quality specifications for antituberculosis fixed dose combination products (opens in a new tab)

  13. Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects

    … pharmacokinetics of rifampicin, isoniazid and pyrazinamide in 76 children with tuberculosis were described using a population pharmacokinetic approach, and then Monte Carlo simulation were performed to evaluate adequacy of newly recommended weight band based doses in World Health Organisation …

    cape-town Repository record for Optimization of 1st-line antituberculosis dosing regimens using a population pharmacokinetic approach: food effects, drug combinations and pharmacological effects (opens in a new tab)

  14. Epidemiologic impact of treatment interventions for tuberculosis control

    … mortality (Chapter II), the effect of re-using pyrazinamide in both first- and second-line treatment on the emergence of extensive drug resistance (Chapter III), and the value of treatment scale-up and programmatic improvements in the control of multidrug-resistant (MDR) TB (Chapter IV). Results …

    jhu Repository record for Epidemiologic impact of treatment interventions for tuberculosis control (opens in a new tab)

  15. Combined first line anti-TB drugs: new insights into stability

    … approach of TB includes rifampicin, isoniazid, pyrazinamide and ethambutol, daily for 2 - 3 months. The use of FDCs may hence simplify treatment and encourage patient compliance, especially in patients who already take numerous medications, when co-infected with human immunodeficiency virus …

    nwu-za Repository record for Combined first line anti-TB drugs: new insights into stability (opens in a new tab)

  16. MECHANISMS OF STAPHYLOCOCCUS AUREUS PERSISTENCE AND ERADICATION OF CHRONIC STAPHYLOCOCCAL INFECTIONS

    … treatment regimen for tuberculosis that includes pyrazinamide, an antipersister drug that targets unconventional drug targets such as proteins involved in energy metabolism and trans-translation. Upon the addition of pyrazinamide, which kill persister bacteria to the combination of rifampin and …

    jhu Repository record for MECHANISMS OF STAPHYLOCOCCUS AUREUS PERSISTENCE AND ERADICATION OF CHRONIC STAPHYLOCOCCAL INFECTIONS (opens in a new tab)

  17. Stability of anti–tuberculosis actives in the PheroidTM delivery system

    … i.e. rifampicin, isoniazid, ethambutol and pyrazinamide, individually, as well as in combination, when incorporated into the pro-Pheroid delivery structure. For analysis, high pressure liquid chromatography was utilised, by using methods that were adjusted and validated according to ICH …

    nwu-za Repository record for Stability of anti–tuberculosis actives in the PheroidTM delivery system (opens in a new tab)

  18. Uso da quimiometria na determinação simultânea do teor dos fármacos em comprimido com dose fixa combinada empregado no tratamento de tuberculose

    … of four drugs: rifampicin, isoniazid, pyrazinamide and ethambutol. With this the treatment is better accepted having a greater adhesion of the patient to the prescribed therapy. Taking into account that the methodology used for the determination of a drug in the presence of excipients …

    brazil-ufrn Repository record for Uso da quimiometria na determinação simultânea do teor dos fármacos em comprimido com dose fixa combinada empregado no tratamento de tuberculose (opens in a new tab)

  19. Desenvolvimento de formulações pediátricas contendo tuberculostáticos

    … containing rifampicin, isoniazid and pyrazinamide in fixed-dose combination for pediatric use. It began with the physico-chemical characterization of active ingredients (identification by IR, UV and HPLC, determination of content by HPLC and UV, bulk density and angle of repose). It …

    brazil-ufrn Repository record for Desenvolvimento de formulações pediátricas contendo tuberculostáticos (opens in a new tab)

  20. Bioactive agents from Grindelia tarapacana Phil. (Asteraceae).

    … to that obtained for the anti-tuberculosis agent pyrazinamide (MIC = 40 μg/mL). Tarapacol diacetate (MIC = 16 μg/mL) was found to be much more potent than pyrazinamide.

    arizona-thes Repository record for Bioactive agents from Grindelia tarapacana Phil. (Asteraceae). (opens in a new tab)

Page 1 of 5